Molecular Characterization and Predictors of Relapse in Patients with Ph + ALL after Frontline Ponatinib and Blinatumomab
Journal of Hematology & Oncology(2025)
Key words
Blinatumomab,Ponatinib,Philadelphia chromosome,Relapse
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined